NEXGEL, Inc. (NXGLW)Langhorne, United States | NasdaqCM
0.03 USD
+0.00
(7.843%)
⇧
(July 13, 2026, 3:08 p.m.
EDT)
After hours: 0.02 0.00 (-0.005%) ⇩ (July 13, 2026, 5:10 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 3:27 a.m. EDT
The investment case here is fundamentally broken. The company is hemorrhaging cash with negative operating and free cash flows, while revenue is shrinking by 5.6%. The balance sheet is precarious, carrying nearly $4.3 million in debt against a mere $208,000 in cash, resulting in a massive debt-to-equity ratio of 95.6. Return on equity is a staggering -61%, indicating severe capital destruction. While the stock trades at a fraction of book value due to these distress factors, there is no evidence of a turnaround; the recent news highlights selling pressure and warrants rather than operational improvements. With no dividend to provide income and a multi-year trajectory of decline implied by the deteriorating fundamentals, this is a clear avoid. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.000000 |
| MSTL | 0.014526 |
| AutoETS | 0.044161 |
| AutoTheta | 0.352180 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 0.00 |
| Ljung-Box p | nan |
| Jarque-Bera p | nan |
| Excess Kurtosis | nan |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 95.627 |
| Revenue per Share | 1.409 |
| Beta | 0.76 |
| Profit Margins | -28.54% |
| Website | https://nexgel.com |
| Attribute | Value |
|---|---|
| Address1 | 2,150 Cabot Boulevard West |
| Address2 | Suite B |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 0.759 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 0.471 |
| City | Langhorne |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0275 |
| Current Ratio | 1.701 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0275 |
| Day Low | 0.0232 |
| Debt To Equity | 95.627 |
| Display Name | NEXGEL |
| Ebitda | -3,098,000 |
| Ebitda Margins | -0.27501 |
| Eps Trailing Twelve Months | -1.39 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0275 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0232 |
| Fifty Two Week Low Change | 0.0043 |
| Fifty Two Week Low Change Percent | 0.18534483 |
| Fifty Two Week Range | 0.0232 - 0.0275 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,783,690,200,000 |
| Float Shares | 7,077,024 |
| Free Cashflow | -2,116,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 19 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.38898998 |
| Gross Profits | 4,382,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-12-22 |
| Language | en-US |
| Long Business Summary | NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania. |
| Long Name | NEXGEL, Inc. |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_315008071 |
| Net Income To Common | -3,215,000 |
| Open | 0.314 |
| Operating Cashflow | -1,415,000 |
| Operating Margins | -0.36151 |
| Phone | 215 702 8550 |
| Post Market Change | -0.004899999 |
| Post Market Change Percent | -17.818178 |
| Post Market Price | 0.0226 |
| Post Market Time | 1,783,977,037 |
| Previous Close | 0.0255 |
| Price Hint | 4 |
| Price To Book | 0.05838641 |
| Profit Margins | -0.2854 |
| Quick Ratio | 0.263 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0020000003 |
| Regular Market Change Percent | 7.843139 |
| Regular Market Day High | 0.0275 |
| Regular Market Day Low | 0.0232 |
| Regular Market Day Range | 0.0232 - 0.0275 |
| Regular Market Open | 0.314 |
| Regular Market Previous Close | 0.0255 |
| Regular Market Price | 0.0275 |
| Regular Market Time | 1,783,969,689 |
| Regular Market Volume | 2,746 |
| Return On Assets | -0.20041999 |
| Return On Equity | -0.61412996 |
| Revenue Growth | -0.056 |
| Revenue Per Share | 1.409 |
| Sand P52 Week Change | 0.20847368 |
| Sector | |
| Sector Key | |
| Short Name | NexGel, Inc Warrant |
| Source Interval | 15 |
| State | PA |
| Symbol | NXGLW |
| Total Cash | 208,000 |
| Total Cash Per Share | 0.023 |
| Total Debt | 4,286,000 |
| Total Revenue | 11,265,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.39 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 2,746 |
| Website | https://nexgel.com |
| Zip | 19,047 |